By the current study, inhibiting the ICOSL seemingly did not change the biofunction of NPC cell itself, suggesting ICOSL influences oncogenesis and tumor progression possible only by enhancing the cytotoxic immunity. Here, ICOSLG is linked to nasopharyngeal carcinoma.